Precision Pharma PTRS Platform
Oncology Drug Development
Commercial/ServiceActive
Key Facts
About Cellworks
Founded in 2005 and headquartered in San Francisco, Cellworks has developed a sophisticated computational biology platform that simulates disease networks to predict therapy responses. The company serves both pharmaceutical clients (through its Precision Pharma offerings) and clinicians/patients (through its Personalized Therapy Decision Support products like SINGULA™ and VENTURA™). Its approach aims to de-risk drug development, optimize clinical trial design, and provide actionable treatment recommendations for refractory cancer patients by evaluating over 20 million potential drug combinations against a patient's unique molecular profile.
View full company profileTherapeutic Areas
Other Oncology Drug Development Drugs
| Drug | Company | Phase |
|---|---|---|
| Pharma R&D Partnership & Biomarker Discovery | Known Medicine | Pre-clinical |
| Pharma R&D & Biobank Services | Encapsulate | Pre-clinical |
| Therapeutics Development | Resolve Biosciences | Research-Use |